NovaLog Mix 50/50 and Oxybutynin Extended-Release Tablets
Determining the interaction of NovaLog Mix 50/50 and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovaLog Mix 50/50-Oxybutynin Gel
- NovaLog Mix 50/50-Oxybutynin Oral Solution
- NovaLog Mix 50/50-Oxybutynin Syrup
- NovaLog Mix 50/50-Oxybutynin Tablets
- NovaLog Mix 50/50-Oxybutynin transdermal
- NovaLog Mix 50/50-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Novamine
- Oxybutynin Extended-Release Tablets-Novamoxin
- Oxybutynin Extended-Release Tablets-Novamoxin Oral
- Oxybutynin Extended-Release Tablets-Novamoxin Reduced Sugar
- Oxybutynin Extended-Release Tablets-Novamoxin Reduced Sugar Oral, Injection, Intravenous, Intramuscular
- Oxybutynin Extended-Release Tablets-Novantrone